Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Department of Medicinal Chemistry

Metabasis Therapeutics

Inc., 11119 North Torrey Pines Road

La Jolla

USA

Name/email consistency: high

Department of Medicinal Chemistry, Metabasis Therapeutics, Inc., 11119 North Torrey Pines Road, La Jolla, USA. 2007
Metabasis Therapeutics Inc, La Jolla, CA 92037, USA. 2006
Research and Development, Metabasis Therapeutics, Inc., 9390 Towne Centre Drive, Building 300, USA. 2005

Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity. Erion, M.D., Dang, Q., Reddy, M.R., Kasibhatla, S.R., Huang, J., Lipscomb, W.N., van Poelje, P.D. J. Am. Chem. Soc. (2007) [Pubmed]
Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index. Erion, M.D., Cable, E.E., Ito, B.R., Jiang, H., Fujitaki, J.M., Finn, P.D., Zhang, B.H., Hou, J., Boyer, S.H., van Poelje, P.D., Linemeyer, D.L. Proc. Natl. Acad. Sci. U.S.A. (2007) [Pubmed]
HepDirect prodrugs for targeting nucleotide-based antiviral drugs to the liver. Erion, M.D., Bullough, D.A., Lin, C.C., Hong, Z. Curr. Opin. Investig. Drugs (2006) [Pubmed]
Liver-targeted drug delivery using HepDirect prodrugs. Erion, M.D., van Poelje, P.D., Mackenna, D.A., Colby, T.J., Montag, A.C., Fujitaki, J.M., Linemeyer, D.L., Bullough, D.A. J. Pharmacol. Exp. Ther. (2005) [Pubmed]
MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes. Erion, M.D., van Poelje, P.D., Dang, Q., Kasibhatla, S.R., Potter, S.C., Reddy, M.R., Reddy, K.R., Jiang, T., Lipscomb, W.N. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]